Back to search results

Observational Study of the XACT ACE Robotic System for Tumors

This study is observing how the XACT ACE Robotic System is used in real-world medical procedures for people with tumors. This system is a hands-free robot that helps doctors plan and guide instruments, like needles, during procedures where CT scans (a type of X-ray) are used. The study aims to see how often the instrument successfully reaches the target, how accurate the system is, and if there are any safety issues. You may be able to join if you are 18 or older and are having a CT-guided, minimally invasive procedure. The study is currently collecting data and plans to include up to 500 participants.

Study design
This is an observational study involving up to 500 participants. It is a single-arm registry, meaning all participants will receive the same intervention.
What's involved
You will undergo a CT-guided, minimally invasive percutaneous procedure where the XACT ACE Robotic System is used. You will also need to sign an informed consent form for data collection.
Compensation
Not stated in the trial record.
Follow-up
Safety will be assessed for up to 2 hours after your procedure. Other outcomes are measured at 1 hour.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04950959

XACT ACE Observational Registry

UNKNOWN
Not specifiedAges 18+Observational
Xact Robotics Ltd.
~500 participants
Updated 2022-10-21 on ClinicalTrials.gov
What's tested:Hands-free, user-controlled robotic system intended to assist in the planning and advancement of an instrument during CT guided percutaneous procedures. T

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of successful procedures
Measured over 1 hour
+2 more outcomes measured

Conditions

Tumors

Explore related trials

Solid Neoplasm

NCT04950959

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Lahey Hospital and Medical Center

    Burlington, Massachusettsstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Mark Macedo · STUDY_DIRECTOR · XACT Robotics

Who to contact

Mark Macedo
[email protected]
5082076505
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

What this trial measures

  • Proportion of successful procedures1 hour

    To evaluate the proportion of procedures in which the instrument reached the pre-defined target based on the physician's determination and CT imaging confirmation.

  • System accuracy1 hour

    To evaluate system accuracy defined as the measured distance from the tip of the instrument to the target location at the end of the instrument insertion.

  • Assessment of Safety2 hours post-procedure

    Incidence of intra- and post-procedural events